Table 1.
Study population demographics
| Group | N (%) | OS total, N (events) | Median follow-up | Median overall survival | p value | CSS total N (events) | Median cancer–specific survival | p value |
|---|---|---|---|---|---|---|---|---|
| Incidental | 158 (33) | 146 (64) | 59.01 (4.70–137.03) | 92.78 (67.06–118.50) | <0.0001 | 146 (4) | Not reached | <0.0001 |
| Advanced | 180 (37) | 172 (132) | 35.93 (0.30–147.55) | 38.60 (30.86–46.35) | 172 (78) | 63.97 (50.65–77.29) | ||
| Castrate resistant | 142 (30) | 134 (113) | 20.85 (2.76–109.24) | 22.24 (13.73–30.75) | 134 (78) | 33.87 (21.84–45.91) | ||
| Overall | 38.77 (0.30–154.97) | 42.12 (37.29–46.95) | Not reached |
CSS = cancer-specific survival; OS = overall survival.